Cargando…

Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer

Kallikrein gene 5 (KLK5, also known as KLK-L2), located on chromosome 19q13.4, is one of the newly identified members of the kallikrein gene family, which is a subgroup of the serine protease enzyme family. In normal human tissues, KLK5 is highly expressed in skin, mammary gland and testis. Prelimin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, H, Scorilas, A, Katsaros, D, Yousef, G M, Massobrio, M, Fracchioli, S, Piccinno, R, Gordini, G, Diamandis, E P
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2001
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363783/ https://www.ncbi.nlm.nih.gov/pubmed/11237385 http://dx.doi.org/10.1054/bjoc.2000.1649

Ejemplares similares

Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker
por: Hoffman, B R, et al.
Publicado: (2002)

Human kallikrein gene 13 (KLK13) expression by quantitative RT–PCR: an independent indicator of favourable prognosis in breast cancer
por: Chang, A, et al.
Publicado: (2002)

Molecular cloning of novel transcripts of human kallikrein-related peptidases 5, 6, 7, 8 and 9 (KLK5 – KLK9), using Next-generation sequencing
por: Adamopoulos, Panagiotis G., et al.
Publicado: (2017)

The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer
por: Yousef, G M, et al.
Publicado: (2002)

Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects
por: Shan, S J C, et al.
Publicado: (2007)

Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies
por: Schmitt, Manfred, et al.
Publicado: (2013)

Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis
por: Yousef, G M, et al.
Publicado: (2002)

Down-regulation of kallikrein-related peptidase 5 (KLK5) expression in breast cancer patients: a biomarker for the differential diagnosis of breast lesions
por: Avgeris, Margaritis, et al.
Publicado: (2011)

Cloning of a gene (SR-A1), encoding for a new member of the human Ser/Arg-rich family of pre-mRNA splicing factors: overexpression in aggressive ovarian cancer
por: Scorilas, A, et al.
Publicado: (2001)

Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer
por: Gong, Weiwei, et al.
Publicado: (2020)

Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes
por: Tamir, Ayala, et al.
Publicado: (2014)

KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma
por: White, N M A, et al.
Publicado: (2009)

Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status
por: Fritzsche, F, et al.
Publicado: (2006)

Kallikrein 5 overexpression is associated with poor prognosis in uterine cervical cancer
por: Chang, Jee Suk, et al.
Publicado: (2020)

Codon 89 polymorphism in the human 5 α -reductase gene in primary breast cancer
por: Scorilas, A, et al.
Publicado: (2001)

The promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines
por: Majumdar, S, et al.
Publicado: (1999)

Development of Chemical Tools to Monitor Human Kallikrein 13 (KLK13) Activity
por: Gruba, Natalia, et al.
Publicado: (2019)

A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival
por: Batra, Jyotsna, et al.
Publicado: (2011)

Analysis of expression and prognosis of KLK7 in ovarian cancer
por: Chen, Erhua, et al.
Publicado: (2020)

Kallikrein gene downregulation in breast cancer
por: Yousef, G M, et al.
Publicado: (2004)

Upregulation of KLK8 Predicts Poor Prognosis in Pancreatic Cancer
por: Hua, Qing, et al.
Publicado: (2021)

Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue
por: Luo, L-Y, et al.
Publicado: (2001)

Kallikrein-Related Peptidase 12 (KLK12) in Breast Cancer as a Favorable Prognostic Marker
por: Sato, Ai, et al.
Publicado: (2023)

The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer
por: Talieri, M, et al.
Publicado: (2009)

Biochemical pathways mediated by KLK6 protease in breast cancer
por: Pampalakis, Georgios, et al.
Publicado: (2019)

Kallikrein-related peptidase-4 (KLK4): role in enamel formation and revelations from ablated mice
por: Bartlett, John D., et al.
Publicado: (2014)

Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma
por: Rückert, F, et al.
Publicado: (2008)

Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer
por: White, N M A, et al.
Publicado: (2010)

KLK5 and KLK7 Ablation Fully Rescues Lethality of Netherton Syndrome-Like Phenotype
por: Kasparek, Petr, et al.
Publicado: (2017)

Mass spectrometry-based determination of Kallikrein-related peptidase 7 (KLK7) cleavage preferences and subsite dependency
por: Silva, Lakmali Munasinghage, et al.
Publicado: (2017)

Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients
por: Gong, Weiwei, et al.
Publicado: (2019)

Evolution of the Plasma and Tissue Kallikreins, and Their Alternative Splicing Isoforms
por: Koumandou, Vassiliki Lila, et al.
Publicado: (2013)

Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer
por: Gong, Weiwei, et al.
Publicado: (2019)

AB73. Effect of human tissue kallikrein 1(hKLK1) on penile erectile function in the aged rat
por: Liu, Ji-Hong
Publicado: (2014)

Genetically-modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)-based targeted therapy (Review)
por: Devetzi, Marina, et al.
Publicado: (2018)

Expression of a prostate-associated protein, human glandular kallikrein (hK2), in breast tumours and in normal breast secretions
por: Black, M H, et al.
Publicado: (2000)

Association of Polymorphism rs198977 in Human Kallikrein-2 Gene (KLK2) with Susceptibility of Prostate Cancer: A Meta-Analysis
por: Wang, Lishan
Publicado: (2013)

Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patients
por: Gong, Weiwei, et al.
Publicado: (2020)

CD5 and CD43 Expression are Associate with Poor Prognosis in DLBCL Patients
por: Huang, Hui, et al.
Publicado: (2018)

KLK5 Inactivation Reverses Cutaneous Hallmarks of Netherton Syndrome
por: Furio, Laetitia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8va71fup4p2p81tnuvpje7bmgb